NovoLog FlexPen — 100 units/mL, Solution for injection, carton of 5 × 3 mL FlexPen prefilled pens

NovoLog FlexPen — 100 units/mL, Solution for injection, carton of 5 × 3 mL FlexPen prefilled pens

NovoLog (insulin aspart) injection, 100 units/mL is supplied for intravenous, subcutaneous use. Rapid-acting insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Supplied as carton of 5 × 3 mL FlexPen prefilled pens; NDC 00169-6339-10; manufacturer Novo Nordisk Inc. Rx only. Store unopened product refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Use the current label for in-use storage limits.

• Active ingredient or product type: insulin aspart
• Strength/concentration: 100 units/mL
• Dosage form and route: Solution for injection, Intravenous, Subcutaneous
• Exact package presentation: carton of 5 × 3 mL FlexPen prefilled pens
• NDC/item number: 00169-6339-10
• Manufacturer/labeler: Novo Nordisk Inc.
• Storage/handling: Store unopened product refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Use the current label for in-use storage limits.
• Status: Rx only

Important safety information: Hypoglycemia is the most common adverse reaction. Do not share insulin delivery devices, and follow the current labeling for administration and storage.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.